LIPELLA PHARMACEUTICALS INC. Earnings Per Share Diluted

Quick Answer

LIPELLA PHARMACEUTICALS INC. reported Earnings Per Share Diluted of $4.79 (loss) per share for the year ending 2024.

  • LIPELLA PHARMACEUTICALS INC. showed an increase of +22.2% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), LIPELLA PHARMACEUTICALS INC.'s Earnings Per Share Diluted has declined by 770.9%.
  • Historical annual values: Fiscal year 2024: $4.79 (loss) per share | Fiscal year 2023: $6.16 (loss) per share | Fiscal year 2022: $0.64 (loss) per share | Fiscal year 2021: $0.55 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: